Cargando…
Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey
INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic poses a challenge to healthcare. Staff and patients are at increased risk during an examination or intervention, so certain restrictions ought to be introduced. Hence, we aimed to measure the effect of the pandemic on endoscopy units in...
Autores principales: | Resál, Tamás, Bor, Renáta, Szántó, Kata, Fábián, Anna, Rutka, Mariann, Sacco, Marco, Ribaldone, Davide Guiseppe, Molander, Pauliina, Nancey, Stephane, Kopylov, Uri, Vavricka, Stephan, Drobne, David, Lukas, Milan, Farkas, Klaudia, Szepes, Zoltán, Molnár, Tamás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072846/ https://www.ncbi.nlm.nih.gov/pubmed/33995580 http://dx.doi.org/10.1177/17562848211006678 |
Ejemplares similares
-
Still the Joker in the Pack: When to Take Out Cyclosporine in the Game?
por: Resál, Tamás, et al.
Publicado: (2021) -
The complex relationship between viruses and inflammatory bowel disease – review and practical advices for the daily clinical decision-making during the SARS-CoV-2 pandemic
por: Farkas, Klaudia, et al.
Publicado: (2021) -
Effect of COVID-19 pandemic on workflows and infection prevention strategies of endoscopy units in Hungary: a cross-sectional survey
por: Bor, Renáta, et al.
Publicado: (2021) -
Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination
por: Resál, Tamás, et al.
Publicado: (2023) -
Ustekinumab is associated with superior treatment persistence but not
with higher remission rates versus vedolizumab in patients with
refractory Crohn’s disease: results from a multicentre cohort
study
por: Bacsur, Péter, et al.
Publicado: (2022)